3 Minutes
The BMW iX is quietly heading for the exit in the United States. What began as a showcase for the brand’s electric ambitions is now giving way to something newer, sharper, and far more important to BMW’s future: Neue Klasse.
BMW has confirmed that U.S. allocations of the iX are ending as the company prepares to roll out its next generation of fully electric vehicles. In a statement shared with BMW Blog, a spokesperson said the lineup is constantly evolving and that the brand is “concluding U.S. allocation of the BMW iX as we prepare for the next generation of our fully electric vehicles.”
The message is hard to miss. The iX did its job.
When BMW launched the electric SUV for the 2022 model year, the goal was never to create a volume leader. It was meant to serve as a rolling statement of intent, showing off the company’s fifth-generation EV technology, bold new styling, and a cabin packed with advanced features. In other words, it was a halo model. A preview. A promise.

Now the spotlight is shifting.
BMW says it remains fully committed to electrification in the U.S., and that commitment is increasingly tied to the Neue Klasse family. Those models will introduce the automaker’s sixth-generation eDrive technology, along with a broader wave of hardware and software upgrades that are expected to influence much of the lineup.
The iX, though, has never been a blockbuster. U.S. sales peaked in 2023 at 17,301 units, before slipping to 15,383 in 2024 and 12,587 in 2025. The trend has only worsened this year, with iX sales down 50.7 percent through the first quarter of 2026, totaling just 1,788 vehicles.
That kind of slide makes BMW’s decision easier to understand. The iX was always designed to open doors, not dominate sales charts.
What happens next is still a little unclear. Production and sales of the iX will continue in other markets for now, and BMW has not said exactly how long the model will remain in production as Neue Klasse vehicles begin to arrive. But in the U.S., the chapter is closing.
Leave a Comment